10 January 2024
10 January 2024
Decentralising cryopreservation also allows sponsors to pick sites that may lack facilities but can enrol a better patient population.
Alcon plans to file for regulatory approval for its dry eye drug with the US Food and Drug Administration (FDA) in mid-2024 after pivotal efficacy and safety studies met the primary endpoints.
Clarametyx Biosciences recently closed a Series A financing round after raising $33m, which will be used for the development of CTMX-101.
The proceeds from the private placement will fund the development of Zealand’s obesity pipeline, including two Phase II candidates.
Following the launch of the technology, Medable will present at the ongoing annual J.P. Morgan Healthcare Conference on 10 January.
The trial’s primary endpoint is to determine the incidence and severity of ocular and systemic adverse events.
In the trial, carvedilol was found to be safe for childhood cancer survivors, potentially improving heart health markers.
The clinical trial for ACT-IOP-003, a targeted pancreatic cancer therapy, is set to begin in mid-2024.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
